• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Invited Commentary on Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8 + T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model.

作者信息

Knight Gabriel, Salem Riad

机构信息

Department of Radiology, Section of Vascular and Interventional Radiology, Northwestern University, 676 N. St. Clair, Suite 800, Chicago, IL, 60611, USA.

出版信息

Cardiovasc Intervent Radiol. 2024 Oct;47(10):1382-1383. doi: 10.1007/s00270-024-03861-3. Epub 2024 Sep 24.

DOI:10.1007/s00270-024-03861-3
PMID:39317872
Abstract
摘要

相似文献

1
Invited Commentary on Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8 + T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model.关于经动脉栓塞增强原位肝癌大鼠模型中程序性细胞死亡配体1表达并影响CD8 + T淋巴细胞细胞毒性的特邀评论
Cardiovasc Intervent Radiol. 2024 Oct;47(10):1382-1383. doi: 10.1007/s00270-024-03861-3. Epub 2024 Sep 24.
2
Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model.经导管动脉栓塞增强了原位肝癌大鼠模型中程序性细胞死亡配体 1 的表达并影响 CD8T 淋巴细胞的细胞毒性。
Cardiovasc Intervent Radiol. 2024 Oct;47(10):1372-1381. doi: 10.1007/s00270-024-03813-x. Epub 2024 Aug 5.
3
Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.经动脉栓塞调节大鼠模型中靶区和非靶区肝细胞癌内的免疫反应。
Radiology. 2022 Apr;303(1):215-225. doi: 10.1148/radiol.211028. Epub 2022 Jan 11.
4
Hepatic Artery Embolization Enhances Expression of Programmed Cell Death 1 Ligand 1 in an Orthotopic Rat Hepatocellular Carcinoma Model: In Vivo and in Vitro Experimentation.肝动脉栓塞增强原位大鼠肝细胞癌模型中程序性细胞死亡蛋白1配体1的表达：体内和体外实验
J Vasc Interv Radiol. 2020 Sep;31(9):1475-1482.e2. doi: 10.1016/j.jvir.2020.03.023. Epub 2020 Aug 14.
5
Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib.经动脉化疗栓塞联合 PD-1 抑制剂加仑伐替尼治疗不可切除肝细胞癌的疗效优于 PD-1 抑制剂加仑伐替尼。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231166765. doi: 10.1177/15330338231166765.
6
Landscape and prognostic values of lymphocytes in patients with hepatocellular carcinoma undergoing transarterial embolization.
J Leukoc Biol. 2024 Jun 28;116(1):186-196. doi: 10.1093/jleuko/qiae094.
7
Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.SIRT7 缺失通过 MEF2D 调控程序性细胞死亡配体 1 增加肝癌细胞中检查点抑制剂的疗效。
Gastroenterology. 2020 Feb;158(3):664-678.e24. doi: 10.1053/j.gastro.2019.10.025. Epub 2019 Oct 31.
8
Transarterial Embolization Using an Inorganic Phosphate Binder Modulates Immunity- and Angiogenesis-Related Factors in a Rat Model of Liver Cancer.使用无机磷酸盐结合剂进行经动脉栓塞调节肝癌大鼠模型中免疫和血管生成相关因子
J Vasc Interv Radiol. 2025 Feb;36(2):320-331.e9. doi: 10.1016/j.jvir.2024.10.010. Epub 2024 Oct 19.
9
Expression and prognostic significance of programmed death protein 1 and programmed death ligand-1, and cytotoxic T lymphocyte-associated molecule-4 in hepatocellular carcinoma.程序性死亡蛋白1、程序性死亡配体-1及细胞毒性T淋巴细胞相关分子4在肝细胞癌中的表达及预后意义
APMIS. 2017 Aug;125(8):690-698. doi: 10.1111/apm.12703. Epub 2017 May 11.
10
Personalized neoantigen vaccine combined with PD-1 blockade increases CD8 tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models.个体化新抗原疫苗联合 PD-1 阻断可增加临床前肝细胞癌模型中 CD8 组织驻留记忆 T 细胞浸润。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2021-004389.

本文引用的文献

1
Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model.经导管动脉栓塞增强了原位肝癌大鼠模型中程序性细胞死亡配体 1 的表达并影响 CD8T 淋巴细胞的细胞毒性。
Cardiovasc Intervent Radiol. 2024 Oct;47(10):1372-1381. doi: 10.1007/s00270-024-03813-x. Epub 2024 Aug 5.
2
Interventional radiology meets immuno-oncology for hepatocellular carcinoma.介入放射学与免疫肿瘤学相遇于肝细胞癌。
J Hepatol. 2024 Jun;80(6):967-976. doi: 10.1016/j.jhep.2022.08.003. Epub 2022 Aug 19.
3
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).
仑伐替尼联合经动脉化疗栓塞术作为晚期肝细胞癌一线治疗的III期随机临床试验（LAUNCH）
J Clin Oncol. 2023 Jan 1;41(1):117-127. doi: 10.1200/JCO.22.00392. Epub 2022 Aug 3.
4
Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model.经导管动脉化疗栓塞术对 VX2 兔肝肿瘤模型免疫细胞募集和免疫检查点标志物表达的影响。
J Vasc Interv Radiol. 2022 Jul;33(7):764-774.e4. doi: 10.1016/j.jvir.2022.03.026. Epub 2022 Mar 26.